|
1
|
Bjornland K, Winberg JO, Odegaard OT,
Hovig E, Loennechen T, Aasen AO, Fodstad O and Maelandsmo GM:
S100A4 involvement in metastasis: Deregulation of matrix
metalloproteinases and tissue inhibitors of matrix
metalloproteinases in osteosarcoma cells transfected with an
anti-S100A4 ribozyme. Cancer Res. 59:4702–4708. 1999.PubMed/NCBI
|
|
2
|
Buetti-Dinh A, Pivkin IV and Friedman R:
S100A4 and its role in metastasis-simulations of knockout and
amplification of epithelial growth factor receptor and matrix
metalloproteinases. Mol Biosyst. 11:2247–2254. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boye K and Maelandsmo GM: S100A4 and
metastasis: A small actor playing many roles. Am J Pathol.
176:528–535. 2010. View Article : Google Scholar :
|
|
4
|
Endo H, Takenaga K, Kanno T, Satoh H and
Mori S: Methionine aminopeptidase 2 is a new target for the
metastasis-associated protein, S100A4. J Biol Chem.
277:26396–26402. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ochiya T, Takenaga K, Asagiri M, Nakano K,
Satoh H, Watanabe T, Imajoh-Ohmi S and Endo H: Efficient inhibition
of tumor angiogenesis and growth by a synthetic peptide blocking
S100A4-methionine aminopeptidase 2 interaction. Mol Ther Methods
Clin Dev. 2:150082015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ishikawa M, Osaki M, Yamagishi M, Onuma K,
Ito H, Okada F and Endo H: Correlation of two distinct
metastasis-associated proteins, MTA1 and S100A4, in angiogenesis
for promoting tumor growth. Oncogene. 38:4715–4728. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kriajevska MV, Cardenas MN, Grigorian MS,
Ambartsumian NS, Georgiev GP and Lukanidin EM: Non-muscle myosin
heavy chain as a possible target for protein encoded by
metastasis-related mts-1 gene. J Biol Chem. 269:19679–19682. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kriajevska M, Bronstein IB, Scott DJ,
Tarabykina S, Fischer-Larsen M, Issinger O and Lukanidin E:
Metastasis-associated protein Mts1 (S100A4) inhibits CK2-mediated
phosphorylation and self-assembly of the heavy chain of nonmuscle
myosin. Biochim Biophys Acta. 1498:252–263. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Watanabe Y, Usada N, Minami H, Morita T,
Tsugane S, Ishikawa R, Kohama K, Tomida Y and Hidaka H:
Calvasculin, as a factor affecting the microfilament assemblies in
rat fibroblasts transfected by src gene. FEBS Lett. 324:51–55.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takenaga K, Nakamura Y, Sakiyama S,
Hasegawa Y, Sato K and Endo H: Binding of pEL98 protein, an
S100-related calcium-binding protein, to nonmuscle tropomyosin. J
Cell Biol. 124:757–768. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kriajevska M, Fischer-Larsen M, Moertz E,
Vorm O, Tulchinsky E, Grigorian M, Ambartsumian N and Lukanidin E:
Liprin beta 1, a member of the family of LAR transmembrane tyrosine
phosphatase-interacting proteins, is a new target for the
metastasis-associated protein S100A4 (Mts1). J Biol Chem.
277:5229–5235. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen M, Bresnick AR and O'Connor KL:
Coupling S100A4 to rhotekin alters Rho signaling output in breast
cancer cells. Oncogene. 32:3754–3764. 2013. View Article : Google Scholar
|
|
13
|
Grigorian M, Andresen S, Tulchinsky E,
Kriajevska M, Carlberg C, Kruse C, Cohn M, Ambartsumian N,
Christensen A, Selivanova G and Lukanidin E: Tumor suppressor p53
protein is a new target for the metastasis-associated Mts1/S100A4
protein: Functional consequences of their interaction. J Biol Chem.
276:22699–22708. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Semov A, Moreno MJ, Onichtchenko A,
Abulrob A, Ball M, Ekiel I, Pietrzynski G, Stanimirovic D and
Alakhov V: Metastasis-associated protein S100A4 induces
angiogenesis through interaction with Annexin II and accelerated
plasmin formation. J Biol Chem. 280:20833–20841. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okada H, Danoff TM, Kalluri R and Neilson
EG: Early role of Fsp1 in epithelial-mesenchymal transformation. Am
J Physiol. 273:F563–F754. 1997.PubMed/NCBI
|
|
16
|
Ning Q, Li F, Wang L, Li H, Yao Y, Hu T
and Sun Z: S100A4 amplifies TGF-β-induced epithelial-mesenchymal
transition in a pleural mesothelial cell line. J Investig Med.
66:334–339. 2018. View Article : Google Scholar
|
|
17
|
Chow KH, Park HJ, George J, Yamamoto K,
Gallup AD, Graber JH, Chen Y, Jiang W, Steindler DA, Neilson EG, et
al: S100A4 is a biomarker and regulator of glioma stem cells that
is critical for mesenchymal transition in glioblastoma. Cancer Res.
77:5360–5373. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lo JF, Yu CC, Chiou SH, Huang CY, Jan CI,
Lin SC, Liu CJ, Hu EY and Yu YH: The epithelial-mesenchymal
transition mediator S100A4 maintains cancer-initiating cells in
head and neck cancers. Cancer Res. 71:1912–1923. 2011. View Article : Google Scholar
|
|
19
|
Guo J, Bian Y, Wang Y, Chen L, Yu A and
Sun X: S100A4 influences cancer stem cell-like properties of MGC803
gastric cancer cells by regulating GDF15 expression. Int J Oncol.
49:559–568. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu Y, Zhou Y, Zhou X, Guo Y, Huang D,
Zhang J, Wang C and Cai L: S100A4 suppresses cancer stem cell
proliferation via interaction with the IKK/NF-κB signaling pathway.
BMC Cancer. 18:7632018. View Article : Google Scholar
|
|
21
|
Conlon GA and Murray GI: Recent advances
in understanding the roles of matrix metalloproteinases in tumour
invasion and metastasis. J Pathol. 247:629–640. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cui N, Hu M and Khalil RA: Biochemical and
biological attributes of matrix metalloproteinases. Prog Mol Biol
Transl Sci. 147:1–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Castro-Castro A, Marchesin V, Monteiro P,
Lodillinsky C, Rosse C and Chavrier P: Cellular and molecular
mechanisms of MT1-MMP-dependent cancer cell invasion. Annu Rev Cell
Dev Biol. 32:555–576. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zarrabi K, Dufour A, Li J, Kuscu C,
Pulkoski-Gross A, Zhi J, Hu Y, Sampson NS, Zucker S and Cao J:
Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer
cell migration. J Biol Chem. 286:33167–33177. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kayano K, Shimada T, Shinomiya T, Nakai S,
Hisa Y, Aoki T, Seiki M and Okada Y: Activation of pro-MMP-2
mediated by MT1-MMP in human salivary gland carcinomas: Possible
regulation of pro-MMP-2 activation by TIMP-2. J Pathol.
202:403–411. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Meirson T and Gil-Henn H: Targeting
invadopodia for blocking breast cancer metastasis. Drug Resist
Updat. 39:1–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koshikawa N, Hoshino D, Taniguchi H,
Minegishi T, Tomari T, Nam SO, Aoki M, Sueta T, Nakagawa T,
Miyamoto S, et al: Proteolysis of EphA2 converts it from a tumor
suppressor to an oncoprotein. Cancer Res. 75:3327–3339. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sakamoto T and Seiki M: Integrated
functions of membrane-type 1 matrix metalloproteinase in regulating
cancer malignancy: Beyond a proteinase. Cancer Sci. 108:1095–1100.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nishida-Aoki N, Tominaga N, Kosaka N and
Ochiya T: Altered biodistribution of deglycosylated extracellular
vesicles through enhanced cellular uptake. J Extracell Vesicles.
9:17135272020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
31
|
Schneider CA, Rasband WS and Eliceiri KW:
NIH image to ImageJ: 25 years of image analysis. Nature Methods.
9:671–675. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hirai M, Minematsu H, Kondo N, Oie K,
Igarashi K and Yamazaki N: Accumulation of liposome with Sialyl
Lewis X to inflammation and tumor region: Application to in vivo
bio-imaging. Biochem Biophys Res Commun. 353:553–558. 2007.
View Article : Google Scholar
|
|
33
|
Condeelis JS, Wyckoff JB, Bailly M,
Pestell R, Lawrence D, Backer J and Segall JE: Lamellipodia in
invasion. Semin Cancer Biol. 11:119–128. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sroka IC, Nagle RB and Bowden GT:
Membrane-type 1 matrix metalloproteinase is regulated by sp1
through the differential activation of AKT, JNK, and ERK pathways
in human prostate tumor cells. Neoplasia. 9:406–417. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hong IK, Byun HJ, Lee J, Jin YJ, Wang SJ,
Jeoung DI, Kim YM and Lee H: The tetraspanin CD81 protein increases
melanoma cell motility by up-regulating metalloproteinase MT1-MMP
expression through the pro-oncogenic Akt-dependent Sp1 activation
signaling pathways. J Biol Chem. 289:15691–15704. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takino T, Nakada M, Li Z, Yoshimoto T,
Domoto T and Sato H: Tip60 regulates MT1-MMP transcription and
invasion of glioblastoma cells through NF-κB pathway. Clin Exp
Metastasis. 33:45–52. 2016. View Article : Google Scholar
|
|
37
|
Haas TL, Stitelman D, Davis SJ, Apte SS
and Madri JA: Egr-1 mediates extracellular matrix-driven
transcription of membrane type 1 matrix metalloproteinase in
endothelium. J Biol Chem. 274:22679–22685. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Heo SH, Lee JY, Yang KM and Park KS: ELK3
Expression correlates with cell migration, invasion, and membrane
type 1-matrix metalloproteinase expression in MDA-MB-231 breast
cancer cells. Gene Expr. 16:197–203. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dulyaninova NG, Malashkevich VN, Almo SC
and Bresnick AR: Regulation of myosin-IIA assembly and Mts1 binding
by heavy chain phosphorylation. Biochemistry. 44:6867–6876. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Masedunskas A, Appaduray MA, Lucas CA,
Cagigas ML, Heydecker M, Holliday M, Meiring JCM, Hook J, Kee A,
White M, et al: Parallel assembly of actin and tropomyosin, but not
myosin II, during de novo actin filament formation in live mice. J
Cell Sci. 131:jcs2126542018. View Article : Google Scholar
|
|
41
|
Lehtimaki J, Hakala M and Lappalainen P:
Actin filament structures in migrating cells. Handb Exp Pharmacol.
235:123–152. 2017. View Article : Google Scholar
|
|
42
|
Tatematsu N, Waguri-Nagaya Y, Kawaguchi Y,
Oguri Y, Ikuta K, Kobayashi M, Nozaki M, Asai K, Aoyama M and
Otsuka T: Mithramycin has inhibitory effects on gliostatin and
matrix metalloproteinase expression induced by gliostatin in
rheumatoid fibroblast-like synoviocytes. Mod Rheumatol. 28:495–505.
2018. View Article : Google Scholar
|
|
43
|
Lee M, Song SU, Ryu JK and Suh JK:
Sp1-dependent regulation of the tissue inhibitor of
metalloproteinases-1 promoter. J Cell Biochem. 91:1260–1268. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
De Clerck YA, Darville MI, Eeckhout Y and
Rousseau GG: Characterization of the promoter of the gene encoding
human tissue inhibitor of metalloproteinases-2 (TIMP-2). Gene.
139:185–191. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li DQ, Pakala SB, Reddy SDN, Ohshiro K,
Zhang JX, Wang L, Zhang Y, de Alborán IM, Pillai MR, Eswaran J and
Kumar R: Bidirectional autoregulatory mechanism of metastasis-
associated protein 1-alternative reading frame pathway in
oncogenesis. Proc Natl Acad Sci USA. 108:8791–8796. 2011.
View Article : Google Scholar
|
|
46
|
Lau JL and Dunn MK: Therapeutic peptides:
Historical perspectives, current development trends, and future
directions. Bioorg Med Chem. 26:2700–2707. 2018. View Article : Google Scholar
|
|
47
|
Katagiri N, Nagatoishi S, Tsumoto K and
Endo H: Structural features of methionine aminopeptidase2-active
core peptide essential for binding with S100A4. Biochem Biophys Res
Commun. 516:1123–1129. 2019. View Article : Google Scholar : PubMed/NCBI
|
